Metabolic outcomes of type 2 diabetes patients with different diabetic durations under the standardized metabolic disease management model

被引：0
|
作者：
杨嘉颖 [1 ]
机构：
[1] Dept Endocrinol Metab,Shanghai General Hosp,Shanghai Jiaotong Univ
来源：
ChinaMedicalAbstracts(InternalMedicine) | 2021年 / 38卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R587.1 [糖尿病];
学科分类号：
1002 ; 100201 ;
摘要：
Objective To explore the metabolic outcomes of type 2 diabetes patients with different durations after 1 year treatment under the standardized metabolic disease management model.Methods( 1) From September 2017 to September 2018,345 type 2 diabetes patients in the Standardized Metabolic Management Center( MMC) of Shanghai General Hospital were recruited and included in this research.
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [31] Type 2 Diabetes Mellitus: A Metabolic Autoinflammatory Disease
    Mandrup-Poulsen, Thomas
    DERMATOLOGIC CLINICS, 2013, 31 (03) : 495 - +
  • [32] Is metabolic acidosis in patients with Type 1 diabetes due to diabetic ketoacidosis?
    Bawa, F. N. Mohideen
    Weston, P. J.
    Walker, J.
    DIABETIC MEDICINE, 2019, 36 : 85 - 86
  • [33] Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease
    Wassink, Annemarie M. J.
    Van Der Graaf, Yolanda
    Soedamah-Muthu, Sabita S.
    Spiering, Wilko
    Visseren, Frank L. J.
    DIABETES & VASCULAR DISEASE RESEARCH, 2008, 5 (02): : 114 - 122
  • [34] Metabolic outcomes in adults with type 2 diabetes and sleep disorders
    Christopher C. Imes
    Zhadyra Bizhanova
    Susan M. Sereika
    Mary T. Korytkowski
    Charles W. Atwood
    Lora E. Burke
    Jacob Kariuki
    Jonna L. Morris
    Robert Stansbury
    Patrick J. Strollo
    Eileen R. Chasens
    Sleep and Breathing, 2022, 26 : 339 - 346
  • [35] Metabolic outcomes in adults with type 2 diabetes and sleep disorders
    Imes, Christopher C.
    Bizhanova, Zhadyra
    Sereika, Susan M.
    Korytkowski, Mary T.
    Atwood, Charles W., Jr.
    Burke, Lora E.
    Kariuki, Jacob
    Morris, Jonna L.
    Stansbury, Robert
    Strollo, Patrick J., Jr.
    Chasens, Eileen R.
    SLEEP AND BREATHING, 2022, 26 (01) : 339 - 346
  • [36] Metabolic Signatures of Type 2 Diabetes Mellitus and Hypertension in COVID-19 Patients With Different Disease Severity
    Elrayess, Mohamed A.
    Cyprian, Farhan S.
    Abdallah, Abdallah M.
    Emara, Mohamed M.
    Diboun, Ilhame
    Anwardeen, Najeha
    Schuchardt, Sven
    Yassine, Hadi M.
    FRONTIERS IN MEDICINE, 2022, 8
  • [37] Type 1 diabetes + metabolic syndrome: need for a different management paradigm?
    Othonos, N.
    Patel, V.
    Saravanan, P.
    DIABETIC MEDICINE, 2014, 31 : 181 - 181
  • [38] Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease:: relationship to metabolic parameters and diabetic complications
    Tarkun, I
    Çetinarslan, B
    Cantürk, Z
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2002, 12 (03) : 127 - 131
  • [39] Association of Succinate and Adenosine Nucleotide Metabolic Pathways with the Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
    Jung, Inha
    Nam, Seungyoon
    Park, Soyoung
    Lee, Da Young
    Yu, Ji Hee
    Seo, Ji A.
    Lee, Dae Ho
    Kim, Nan Hee
    DIABETES, 2024, 73
  • [40] Impact of metabolic syndrome and myocardial infarction on cardiovascular outcomes in patients with type 2 diabetes
    Pereira, V. S.
    Rodgerio, T.
    Relvas, W. G. M.
    Pinto, L. D. E. S. A.
    Ihara, S. S. M.
    Heifenstein, T.
    Povoa, R. M. S.
    Novazzi, J. P.
    Kasinski, N.
    Carvalho, A. C. C.
    Fonseca, F. A. H.
    Izar, M. C. O.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (03) : 1 - 1
12345